CD274 and cancer: Such checkpoints are composed of the ligands on the cancer cells and the complementary receptors on the CD8+ T cell, and the most known bindings include PD-1/PD-L1, CD80-CD86/CTLA4, MHC II/LAG3, CD155/TIGIT, GAL9/TIM3, and others [58].